glutathione levels in liver disease disulfide sensitizes hepatocytes to TNFα-mediated cytotoxicity via IKK-β S-glutathionylation: a potential mechanism underlying non-alcoholic fatty Effect of administration of HGV1

The closest human evidence in its drug class is Athira Pharma's fosgonimeton (ATH-1017), a structurally distinct molecule in the same HGF/c-Met program whose Phase 2/3 LIFT-AD Alzheimer's trial failed its primary endpoint in September 2024 (GST 0.08, P=.70)

Reconstituting too early: Only reconstitute a vial when you are ready to start using it

Understanding the gutbrain axis and its therapeutic implications for neurodegenerative disorders

CONVERGE consortium

Using individual variation in GSH combined with a repeated measures approach is a highly effective form of randomization

A case series (GSH soap: 15 patients) reported skin lightening based on photography